Sbir topic 368: user-friendly, platform-independent software will be developed to incorporate validated, in vivo dosimetry from targeted radiotherapy into pre-treatment plans that use external…
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201700038C
- Awardee
-
Radiopharmaceutical Imaging And Dosimetry, LLC UEI CM3LK9281JS7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,466
Award facts
- Opportunity
-
- PHS20171 Solicitation number
- Contract value 100% obligated
- $299,466.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21231, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $299,466 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Radiopharmaceutical Imaging And Dosimetry, LLC (doing business as Radiopharmaceutical Imaging & Dosimetry LLC), a for-profit limited liability company. The $299,466.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of user-friendly, platform-independent software to incorporate validated, in vivo dosimetry from targeted radiotherapy into pre-treatment plans that use external radiotherapy. The contract has a completion date of October 17, 2018. Radiopharmaceutical Imaging And Dosimetry has prior experience providing services related to quantitative imaging, dosimetry, and treatment optimization for metastatic liver cancer and prostate cancer patients under past federal contracts and grants.
Description
Sbir topic 368: user-friendly, platform-independent software will be developed to incorporate validated, in vivo dosimetry from targeted radiotherapy into pre-treatment plans that use external radiotherapy.
Quick answers
Who was awarded contract HHSN261201700038C?
HHSN261201700038C was awarded to Radiopharmaceutical Imaging And Dosimetry, LLC by National Cancer Institute (National Institutes of Health) on September 18, 2017.
How much is contract HHSN261201700038C worth?
The government has obligated $299,466 on HHSN261201700038C.
Was contract HHSN261201700038C competed?
The extent of competition for HHSN261201700038C was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award